View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
 PRESS RELEASE

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the Phase 3 ABTECT Program and Preclinical Anti-Fibrotic Models in Inflammatory Bowel Disease PARIS, France – April 22, 2026 – 10:05 pm CEST – (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immun...

 PRESS RELEASE

GTT: Q1 2026 Activity Update - Press Release

GTT: Q1 2026 Activity Update - Press Release Strong commercial momentum in the first quarter of 2026;Revenues of 193 million euros, in line with expectations Strong commercial momentum: In the first quarter of 2026, 32 orders recorded compared with 16 in the first quarter of 2025Revenues of 193 million euros, up 1% compared with the first quarter of 2025To date, the Middle East conflict has no direct impact on GTT’s business activity; 2026 objectives confirmed Paris, April 22, 2026. GTT, the technological expert in membrane containment systems used to transport and store liquefied gases,...

 PRESS RELEASE

GTT: Activité du 1er trimestre 2026 - Communiqué de Presse

GTT: Activité du 1er trimestre 2026 - Communiqué de Presse Forte dynamique commerciale au premier trimestre 2026 ;Chiffre d’affaires de 193 M€ conforme aux attentes Forte dynamique commerciale : 32 commandes enregistrées au premier trimestre 2026 vs 16 au premier trimestre 2025Chiffre d’affaires de 193 millions d’euros, en hausse de 1% par rapport au premier trimestre 2025 A date le conflit au Moyen-Orient n’a pas d’impact direct sur l’activité de GTT ; objectifs 2026 confirmés Paris – Le 22 avril 2026. GTT, l'expert technologique des systèmes de confinement à membranes dédiés au transpo...

Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
Carole Braudeau
  • Carole Braudeau

Credit Morning 04/21/2026

OPmobility outperformed in Q1 2026 thanks to its fuel tank business|Emeria: Moody’s downgrades its outlook as the group seeks a consensual agreement|

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch